Cdkn1c - cyclin-dependent kinase inhibitor 1C

Predicted to enable protein kinase inhibitor activity. Predicted to be involved in several processes, including negative regulation of cell cycle; positive regulation of transforming growth factor beta receptor signaling pathway; and regulation of transcription, DNA-templated. Predicted to act upstream of or within several processes, including animal organ development; genetic imprinting; and regulation of exit from mitosis. Predicted to be located in cytoplasm and nucleus. Human ortholog(s) of this gene implicated in Beckwith-Wiedemann syndrome; IMAGe syndrome; and hyperinsulinism. Orthologous to human CDKN1C (cyclin dependent kinase inhibitor 1C). [provided by Alliance of Genome Resources, Apr 2022]